NCT06730503View on ClinicalTrials.gov

Glycoprotein in Immunotherapy Response and Efficacy Prediction of Lung Cancer

RecruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

October 31, 2027

Study Completion Date

October 31, 2028

Conditions
Non Small Cell Lung Cancer
Interventions
DRUG

Immune checkpoint inhibitor

Observe a situation before and after immunotherapy

Trial Locations (1)

200030

RECRUITING

Xiaomin Niu, Shanghai

All Listed Sponsors
lead

Shanghai Chest Hospital

OTHER